Tenders Are Invited For Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Contract According To Section 130A Paragraph 8 Or 130C Paragraph 1 Sgb V For The Period From March 1St, 2026 To Usually February 29Th, 2028

Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Contract According To Section 130A Paragraph 8 Or 130C Paragraph 1 Sgb V For The Period From March 1St, 2026 To Usually February 29Th, 2028. Active Ingredient Atropine Sulfate; Atc Code S01fa01; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Ertugliflozin; Atc Code A10bk04; Dosage Form Film-Coated Tablets; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Brensocatib; Atc Code R03; Dosage Form Film-Coated Tablets; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Etanercept; Atc Code L04ab01; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Lidocaine; Atc Code N01bb02; Dosage Form Pfl; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Ribociclib; Atc Code L01ef02; Dosage Form Film-Coated Tablets; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Tacrolimus; Atc Code L04ad02; Dosage Form Hkp, Rek; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Tamsulosin Hydrochloride; Atc Code G04ca02; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs)